Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta

被引:81
作者
Batocchi, AP
Rotondi, M
Caggiula, M
Frisullo, G
Odoardi, F
Nociti, V
Carella, C
Tonali, PA
Mirabella, M
机构
[1] Catholic Univ, Neurol Inst, I-00168 Rome, Italy
[2] Univ Naples, F Magrassi Inst Endocrinol II, Dept Clin & Expt Med, I-80121 Naples, Italy
关键词
leptin; cytokines; multiple sclerosis; interferon beta;
D O I
10.1016/S0165-5728(03)00154-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of leptin was investigated in relapsing-remitting multiple sclerosis (MS). Control and MS patients showed comparable baseline serum leptin levels. During the first year of IFNbeta-1a treatment, leptin significantly decreased since 2 months after starting therapy in 11 patients who had no relapses. A significant decrease in IL12/IL10 ratio was observed in this group of patients only after I year of treatment. An increase of leptin was observed before the first clinical exacerbation in 13 relapsing patients. Leptin may play a pathogenic role in MS and can be a useful marker of disease activity and response to therapy. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:150 / 154
页数:5
相关论文
共 16 条
  • [1] Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production
    Byrnes, AA
    McArthur, JC
    Karp, CL
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (02) : 165 - 174
  • [2] Considerations in the treatment of relapsing-remitting multiple sclerosis
    Calabresi, PA
    [J]. NEUROLOGY, 2002, 58 (08) : S10 - S22
  • [3] Leptin and the regulation of body weight in mammals
    Friedman, JM
    Halaas, JL
    [J]. NATURE, 1998, 395 (6704) : 763 - 770
  • [4] Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse
    Gayo, A
    Mozo, L
    Suárez, A
    Tuñon, TB
    Lahoz, C
    Gutiérrez, C
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (02) : 122 - 130
  • [5] Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis
    Kahl, KG
    Kruse, N
    Toyka, KV
    Rieckmann, P
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 200 (1-2) : 53 - 55
  • [6] Leptin regulates proinflammatory immune responses
    Loffreda, S
    Yang, SQ
    Lin, HZ
    Karp, CL
    Brengman, ML
    Wang, DJ
    Klein, AS
    Bulkley, GB
    Bao, C
    Noble, PW
    Lane, MD
    Diehl, AM
    [J]. FASEB JOURNAL, 1998, 12 (01) : 57 - 65
  • [7] Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
    Lord, GM
    Matarese, G
    Howard, LK
    Baker, RJ
    Bloom, SR
    Lechler, RI
    [J]. NATURE, 1998, 394 (6696) : 897 - 901
  • [8] Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome
    Masuzaki, H
    Ogawa, Y
    Hosoda, K
    Miyawaki, T
    Hanaoka, I
    Hiraoka, J
    Yasuno, A
    Nishimura, H
    Yoshimasa, Y
    Nishi, S
    Nakao, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) : 2542 - 2547
  • [9] Balancing susceptibility to infection and autoimmunity: a role for leptin?
    Matarese, G
    La Cava, A
    Sanna, V
    Lord, GM
    Lechler, RI
    Fontana, S
    Zappacosta, S
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (04) : 182 - 187
  • [10] Requirement for leptin in the induction and progression of autoimmune encephalomyelitis
    Matarese, G
    Di Giacomo, A
    Sanna, V
    Lord, GM
    Howard, JK
    Di Tuoro, A
    Bloom, SR
    Lechler, RI
    Zappacosta, S
    Fontana, S
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 5909 - 5916